Medication
Jack’s father, Paul, was diagnosed with a rare form of early-onset Alzheimer’s disease. He died in 2023 at the age of 66, following years of profound change for the whole family.
Donanemab: NHS won’t fund new Alzheimer’s drug
Despite disappointment at Donanemab decision, NICE must consider funding to support dementia and carers.
Lecanemab UK license for Alzheimer’s, not recommended by NICE
Lecanemab drug treatment for early Alzheimers is licensed for UK use; NICE must consider funding to support dementia and carers.